Metabolism of debrisoquine and susceptibility to breast cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1991-03

AUTHORS

Jens Huober, Barbara Bertram, Edgar Petru, Manfred Kaufmann, Dietrich Schmähl

ABSTRACT

There may exist an association between the genetically determined oxidation status of the antihypertensive agent debrisoquine (DEB) and the propensity to develop tumours. The metabolism of DEB is extensive in 90% of healthy subjects (metabolic ratio=MR=0–12.6; MR=% DEB excreted divided by % 4-hydroxy-DEB excreted) and poor in 10% (MR >12.6). In patients with cancer of the lung, urinary bladder, and gastrointestinum, the percentage of high metabolizers is increased to >98%. The poor metabolizer mode is almost devoid of cancer patients. It was investigated whether breast cancer patients show a similar association with respect to the oxidative status of DEB. 108 breast cancer patients and 123 women with benign gynecologic disorders received 1 tablet of 10 mg DEB orally in the evening. Urine was collected for the subsequent 8 hrs and analysed for its content of DEB and its main urinary metabolite 4-OH-DEB by means of HPLC. No decreased amount of poor metabolizers was seen in the cancer group. More... »

PAGES

43-48

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf01975442

DOI

http://dx.doi.org/10.1007/bf01975442

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1006095234

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1854978


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromatography, High Pressure Liquid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Debrisoquin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Susceptibility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, 6900, Heidelberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, 6900, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huober", 
        "givenName": "Jens", 
        "id": "sg:person.01202017435.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202017435.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, 6900, Heidelberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, 6900, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bertram", 
        "givenName": "Barbara", 
        "id": "sg:person.01101743177.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101743177.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dept. of Obstetrics and Gynecology, University, Graz, Austria", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Dept. of Obstetrics and Gynecology, University, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petru", 
        "givenName": "Edgar", 
        "id": "sg:person.01063471533.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063471533.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dept. of Obstetrics and Gynecology, University, Heidelberg, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Dept. of Obstetrics and Gynecology, University, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaufmann", 
        "givenName": "Manfred", 
        "id": "sg:person.01152124005.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152124005.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, 6900, Heidelberg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, 6900, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schm\u00e4hl", 
        "givenName": "Dietrich", 
        "id": "sg:person.0105462430.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-3-642-81043-5_2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029488592", 
          "https://doi.org/10.1007/978-3-642-81043-5_2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1989.142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039682672", 
          "https://doi.org/10.1038/bjc.1989.142"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/331442a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032224836", 
          "https://doi.org/10.1038/331442a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/312169a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044514040", 
          "https://doi.org/10.1038/312169a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-96830-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040800323", 
          "https://doi.org/10.1007/978-3-642-96830-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01774220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032441977", 
          "https://doi.org/10.1007/bf01774220"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1991-03", 
    "datePublishedReg": "1991-03-01", 
    "description": "There may exist an association between the genetically determined oxidation status of the antihypertensive agent debrisoquine (DEB) and the propensity to develop tumours. The metabolism of DEB is extensive in 90% of healthy subjects (metabolic ratio=MR=0\u201312.6; MR=% DEB excreted divided by % 4-hydroxy-DEB excreted) and poor in 10% (MR >12.6). In patients with cancer of the lung, urinary bladder, and gastrointestinum, the percentage of high metabolizers is increased to >98%. The poor metabolizer mode is almost devoid of cancer patients. It was investigated whether breast cancer patients show a similar association with respect to the oxidative status of DEB. 108 breast cancer patients and 123 women with benign gynecologic disorders received 1 tablet of 10 mg DEB orally in the evening. Urine was collected for the subsequent 8 hrs and analysed for its content of DEB and its main urinary metabolite 4-OH-DEB by means of HPLC. No decreased amount of poor metabolizers was seen in the cancer group.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf01975442", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1092777", 
        "issn": [
          "0167-6806", 
          "1573-7217"
        ], 
        "name": "Breast Cancer Research and Treatment", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "breast cancer patients", 
      "metabolism of debrisoquine", 
      "cancer patients", 
      "benign gynecologic disorders", 
      "main urinary metabolite", 
      "cancer group", 
      "gynecologic disorders", 
      "urinary bladder", 
      "breast cancer", 
      "healthy subjects", 
      "poor metabolizers", 
      "urinary metabolites", 
      "patients", 
      "similar association", 
      "debrisoquine", 
      "high metabolizers", 
      "oxidative status", 
      "metabolizers", 
      "cancer", 
      "decreased amount", 
      "oxidation status", 
      "association", 
      "metabolism", 
      "status", 
      "gastrointestinum", 
      "means of HPLC", 
      "bladder", 
      "lung", 
      "tumors", 
      "women", 
      "urine", 
      "disorders", 
      "hr", 
      "subjects", 
      "metabolites", 
      "group", 
      "susceptibility", 
      "percentage", 
      "evening", 
      "tablets", 
      "HPLC", 
      "propensity", 
      "means", 
      "amount", 
      "content", 
      "respect", 
      "mode"
    ], 
    "name": "Metabolism of debrisoquine and susceptibility to breast cancer", 
    "pagination": "43-48", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1006095234"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf01975442"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1854978"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf01975442", 
      "https://app.dimensions.ai/details/publication/pub.1006095234"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_241.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf01975442"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01975442'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01975442'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01975442'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01975442'


 

This table displays all metadata directly associated to this object as RDF triples.

189 TRIPLES      21 PREDICATES      85 URIs      71 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf01975442 schema:about N473f4891e26a4eb1aa7a7a0898edc023
2 N65b101393ca84024a9edef12d333c943
3 Nc10449afc78d4397b05c2b8385ff54e4
4 Nc4c9e8f7b236436bb8591c646bc2571d
5 Ne60a284db4564ab8b20984ecd55264bd
6 Nea9b99a9898b4a97b4d6405c16f332ea
7 anzsrc-for:11
8 anzsrc-for:1112
9 schema:author Nc174aa9d20284f5780373bc728759bf5
10 schema:citation sg:pub.10.1007/978-3-642-81043-5_2
11 sg:pub.10.1007/978-3-642-96830-3
12 sg:pub.10.1007/bf01774220
13 sg:pub.10.1038/312169a0
14 sg:pub.10.1038/331442a0
15 sg:pub.10.1038/bjc.1989.142
16 schema:datePublished 1991-03
17 schema:datePublishedReg 1991-03-01
18 schema:description There may exist an association between the genetically determined oxidation status of the antihypertensive agent debrisoquine (DEB) and the propensity to develop tumours. The metabolism of DEB is extensive in 90% of healthy subjects (metabolic ratio=MR=0–12.6; MR=% DEB excreted divided by % 4-hydroxy-DEB excreted) and poor in 10% (MR >12.6). In patients with cancer of the lung, urinary bladder, and gastrointestinum, the percentage of high metabolizers is increased to >98%. The poor metabolizer mode is almost devoid of cancer patients. It was investigated whether breast cancer patients show a similar association with respect to the oxidative status of DEB. 108 breast cancer patients and 123 women with benign gynecologic disorders received 1 tablet of 10 mg DEB orally in the evening. Urine was collected for the subsequent 8 hrs and analysed for its content of DEB and its main urinary metabolite 4-OH-DEB by means of HPLC. No decreased amount of poor metabolizers was seen in the cancer group.
19 schema:genre article
20 schema:isAccessibleForFree false
21 schema:isPartOf N9bcbc8cda69c46bc898bb89cbbb11652
22 Nb16c88df116f4af2a081582d00d056c2
23 sg:journal.1092777
24 schema:keywords HPLC
25 amount
26 association
27 benign gynecologic disorders
28 bladder
29 breast cancer
30 breast cancer patients
31 cancer
32 cancer group
33 cancer patients
34 content
35 debrisoquine
36 decreased amount
37 disorders
38 evening
39 gastrointestinum
40 group
41 gynecologic disorders
42 healthy subjects
43 high metabolizers
44 hr
45 lung
46 main urinary metabolite
47 means
48 means of HPLC
49 metabolism
50 metabolism of debrisoquine
51 metabolites
52 metabolizers
53 mode
54 oxidation status
55 oxidative status
56 patients
57 percentage
58 poor metabolizers
59 propensity
60 respect
61 similar association
62 status
63 subjects
64 susceptibility
65 tablets
66 tumors
67 urinary bladder
68 urinary metabolites
69 urine
70 women
71 schema:name Metabolism of debrisoquine and susceptibility to breast cancer
72 schema:pagination 43-48
73 schema:productId N5d38d65ff74d4a53a32ea4980d1b8721
74 Nabbcf40bd95440fa9db6fa697a496ccb
75 Ndffc92e7315e40678886154de931a079
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006095234
77 https://doi.org/10.1007/bf01975442
78 schema:sdDatePublished 2022-12-01T06:20
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher N2a71e7c882314964af659086c893c339
81 schema:url https://doi.org/10.1007/bf01975442
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N1dad245ea08f476fbd8ab6867faf55d8 rdf:first sg:person.01152124005.15
86 rdf:rest N26402bea3aad4d99883c101a3e5a00d5
87 N26402bea3aad4d99883c101a3e5a00d5 rdf:first sg:person.0105462430.55
88 rdf:rest rdf:nil
89 N2a71e7c882314964af659086c893c339 schema:name Springer Nature - SN SciGraph project
90 rdf:type schema:Organization
91 N473f4891e26a4eb1aa7a7a0898edc023 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Female
93 rdf:type schema:DefinedTerm
94 N5d38d65ff74d4a53a32ea4980d1b8721 schema:name dimensions_id
95 schema:value pub.1006095234
96 rdf:type schema:PropertyValue
97 N65b101393ca84024a9edef12d333c943 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Chromatography, High Pressure Liquid
99 rdf:type schema:DefinedTerm
100 N7118237779774a7dac7c37372f5baaff rdf:first sg:person.01101743177.56
101 rdf:rest N9ef11e11739e40f9ac41f34b917b034e
102 N9bcbc8cda69c46bc898bb89cbbb11652 schema:volumeNumber 18
103 rdf:type schema:PublicationVolume
104 N9ef11e11739e40f9ac41f34b917b034e rdf:first sg:person.01063471533.53
105 rdf:rest N1dad245ea08f476fbd8ab6867faf55d8
106 Nabbcf40bd95440fa9db6fa697a496ccb schema:name doi
107 schema:value 10.1007/bf01975442
108 rdf:type schema:PropertyValue
109 Nb16c88df116f4af2a081582d00d056c2 schema:issueNumber 1
110 rdf:type schema:PublicationIssue
111 Nc10449afc78d4397b05c2b8385ff54e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Humans
113 rdf:type schema:DefinedTerm
114 Nc174aa9d20284f5780373bc728759bf5 rdf:first sg:person.01202017435.02
115 rdf:rest N7118237779774a7dac7c37372f5baaff
116 Nc4c9e8f7b236436bb8591c646bc2571d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Debrisoquin
118 rdf:type schema:DefinedTerm
119 Ndffc92e7315e40678886154de931a079 schema:name pubmed_id
120 schema:value 1854978
121 rdf:type schema:PropertyValue
122 Ne60a284db4564ab8b20984ecd55264bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Disease Susceptibility
124 rdf:type schema:DefinedTerm
125 Nea9b99a9898b4a97b4d6405c16f332ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Breast Neoplasms
127 rdf:type schema:DefinedTerm
128 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
129 schema:name Medical and Health Sciences
130 rdf:type schema:DefinedTerm
131 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
132 schema:name Oncology and Carcinogenesis
133 rdf:type schema:DefinedTerm
134 sg:journal.1092777 schema:issn 0167-6806
135 1573-7217
136 schema:name Breast Cancer Research and Treatment
137 schema:publisher Springer Nature
138 rdf:type schema:Periodical
139 sg:person.0105462430.55 schema:affiliation grid-institutes:grid.7497.d
140 schema:familyName Schmähl
141 schema:givenName Dietrich
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55
143 rdf:type schema:Person
144 sg:person.01063471533.53 schema:affiliation grid-institutes:None
145 schema:familyName Petru
146 schema:givenName Edgar
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063471533.53
148 rdf:type schema:Person
149 sg:person.01101743177.56 schema:affiliation grid-institutes:grid.7497.d
150 schema:familyName Bertram
151 schema:givenName Barbara
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101743177.56
153 rdf:type schema:Person
154 sg:person.01152124005.15 schema:affiliation grid-institutes:None
155 schema:familyName Kaufmann
156 schema:givenName Manfred
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152124005.15
158 rdf:type schema:Person
159 sg:person.01202017435.02 schema:affiliation grid-institutes:grid.7497.d
160 schema:familyName Huober
161 schema:givenName Jens
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202017435.02
163 rdf:type schema:Person
164 sg:pub.10.1007/978-3-642-81043-5_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029488592
165 https://doi.org/10.1007/978-3-642-81043-5_2
166 rdf:type schema:CreativeWork
167 sg:pub.10.1007/978-3-642-96830-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040800323
168 https://doi.org/10.1007/978-3-642-96830-3
169 rdf:type schema:CreativeWork
170 sg:pub.10.1007/bf01774220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032441977
171 https://doi.org/10.1007/bf01774220
172 rdf:type schema:CreativeWork
173 sg:pub.10.1038/312169a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044514040
174 https://doi.org/10.1038/312169a0
175 rdf:type schema:CreativeWork
176 sg:pub.10.1038/331442a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032224836
177 https://doi.org/10.1038/331442a0
178 rdf:type schema:CreativeWork
179 sg:pub.10.1038/bjc.1989.142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039682672
180 https://doi.org/10.1038/bjc.1989.142
181 rdf:type schema:CreativeWork
182 grid-institutes:None schema:alternateName Dept. of Obstetrics and Gynecology, University, Graz, Austria
183 Dept. of Obstetrics and Gynecology, University, Heidelberg, Germany
184 schema:name Dept. of Obstetrics and Gynecology, University, Graz, Austria
185 Dept. of Obstetrics and Gynecology, University, Heidelberg, Germany
186 rdf:type schema:Organization
187 grid-institutes:grid.7497.d schema:alternateName Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, 6900, Heidelberg, Germany
188 schema:name Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, 6900, Heidelberg, Germany
189 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...